Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Trading Statement

24 Feb 2016 07:00

RNS Number : 9368P
Microsaic Systems plc
24 February 2016
 

Microsaic Systems plc

 

("Microsaic", "Microsaic Systems" or the "Company") 

Update on Operations and Notice of Results

 

24 February 2016

 

Microsaic Systems plc (AIM: MSYS), the developer of miniaturised chip-based scientific instruments, announces an improved business performance in the six months to 31 December 2015. The Company sold seventeen 4000 MiD® units in H2 2015 versus six units in H1 2015. The Board anticipates that sales for H1 2016 will continue this positive trend. The Company is pleased to announce that it has also signed a new distributor agreement for the 4000 MiD®; details of which will be provided in the 2015 Annual Report.

 

The Company also announces that following a strategic review of the route-to-market for its advanced "triple quad" technology, the Company's development agreement announced on 25 September 2014 with an OEM partner has been terminated. The Company aims to finalise the development of its first triple quad prototype in the middle of 2016 and begin preliminary testing for defined applications. These actions will enable the Company to pursue a strategy of multiple outlets into each application area and hence reduce its dependency on any one international market participant.

 

Furthermore, the Company has identified a number of innovative new application areas for its current "single quad" products and early stage contacts are being made with appropriate companies to be partners for these. As a result, further OEM contracts are expected through 2016 and 2017. The Company has completed a review of its sales and marketing strategy, training and client literature - the results of which are in the process of being implemented.

 

The Company will announce its preliminary results for the year ended 31 December 2015 around 16 March 2016.

 

Enquiries:

 

Microsaic Systems plc

via Citigate Dewe Rogerson

Colin Nicholl, Chairman

 

Jim Ramage, CEO

 

 

 

Numis Securities Limited

+44 (0)20 7260 1000

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

 

 

 

Citigate Dewe Rogerson (Financial PR)

+44 (0)20 7282 2948/1068

Mark Swallow, Marine Perrier

 

 

About Microsaic Systems

 

Microsaic Systems plc is a high technology company developing and marketing next generation mass spectrometry (MS) instruments for the analysis of gaseous, liquid and solid samples. Microsaic has successfully miniaturised mass spectrometry into a desktop instrument by integrating the key MS components onto patented chip technologies (called ionchip®, spraychip® and vac-chip™). Microsaic's MS products retain the functionality of larger, conventional MS systems but are substantially smaller, lighter, consume less energy and have lower running costs. The Microsaic 4000 MiD® is the world's smallest MS system.

 

Mass spectrometry is a 'gold-standard' analytical technique used across many industry sectors, including pharmaceutical, diagnostics and healthcare, government, energy, utilities, environmental, food and drink, security and defence, and industrial chemicals - a combined market estimated to grow to $2.5 billion by 2017. Microsaic aims to introduce compact, deployable MS products, based on its core technology, into a series of these target markets.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS. www.microsaic.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLFFIFFRIVFIR
Date   Source Headline
24th Nov 20222:00 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:25 amRNSSupply of mass spectroscopy services to DeepVerge
22nd Aug 20227:00 amRNSPartnership with Kingfield Electronics
5th Jul 20224:41 pmRNSSecond Price Monitoring Extn
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20222:06 pmRNSSecond Price Monitoring Extn
5th Jul 20222:01 pmRNSPrice Monitoring Extension
4th Jul 20224:43 pmRNSReplacement: Trading Update
1st Jul 20222:09 pmRNSHolding(s) in Company
30th Jun 202212:11 pmRNSResult of AGM
30th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSPosting of Annual Report & Notice of AGM
30th May 20227:00 amRNSFinal Results
19th Apr 20227:00 amRNSManufacturing Services Framework Agreement
28th Mar 20227:30 amRNSUpdate on Microsaic's miniaturised technology
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.